In December 2018, it was announced that GSK Consumer Healthcare will merge with HUL an all-stock deal, valuing the Indian unit of GSK at Rs...

GSK brands like Horlicks, Boost, Maltova and Viva have come to HUL’s portfolio as part of the merger.

Officials aware of the developments say Morgan Stanley is readying the share sale process.

The company is hoping to cash out what will be a near 6 per cent stake in HUL.

The unlisted entity has brands like Sensodyne toothpaste, Crocin analgesic and Iodex pain balm. The majority of GSK Consumer’s India portfo...

The company has received 99.99 per cent votes in favour of the scheme of amalgamation.

The company's total income stood at Rs 1,241.07 crore, up 12.82 per cent.

Unilever Plc’s India unit said on December 3 it would merge GSK Consumer with itself in an all-stock deal that will give it access to Horli...

On December 3, 2018, HUL had informed that its board has approved the merger with GSKCH India through an-all equity deal, valuing the total...

GSK Consumer Healthcare said it will contest an attempt by Steer Engineering to block the transfer of technology that quickens the process ...

Unilever bought back HUL shares at Rs 600 apiece 5 years ago which has appreciated to Rs 1,700 now. Unilever diluted 5.3% HUL stake in GSK ...

GSK chief strategy officer said there is no clause in the deal that HUL has to retain all GSKCH employees.

Unilever edged past Nestle, the world’s largest food and drinks company, in a closely fought battle.

HUL has invested almost Rs 3,000 crore in the foods business over the last 10 years.

The scrip was 1.57 per cent up at Rs 7,383.85 at around 02.27 pm.

In response to recent press speculation, GSK confirms that consideration is being given to a potential transaction that includes a merger o...

GSK had conducted an internal analysis involving tax experts in Europe and India and a handful of external tax consultants in UK to discove...